Jahr JS - Search Results

1

Hemoglobin glutamer-250 (bovine) in South Africa: consensus usage guidelines from clinician experts who have treated patients.

Mer M, Hodgson E, Wallis L, Jacobson B, Levien L, Snyman J, Sussman MJ, James M, van Gelder A, Allgaier R, Jahr JS. Mer M, et al. Among authors: jahr js. Transfusion. 2016 Oct;56(10):2631-2636. doi: 10.1111/trf.13726. Epub 2016 Sep 23. Transfusion. 2016. PMID: 27658499

2

Effects of hemoglobin glutamer-250 (bovine) (HBOC-201, Hemopure) on coagulation testing.

Jahr JS, Lurie F, Gosselin R, Lin JS, Wong L, Owings JT, Larkin E. Jahr JS, et al. Am J Ther. 2002 Sep-Oct;9(5):431-6. doi: 10.1097/00045391-200209000-00011. Am J Ther. 2002. PMID: 12237736

3

Validation of oxygen saturation measurements in a canine model of hemoglobin-based oxygen carrier infusion.

Jahr JS, Lurie F, Driessen B, Tang Z, Louie RF, Kost G. Jahr JS, et al. Am J Ther. 2003 Jan-Feb;10(1):21-8. doi: 10.1097/00045391-200301000-00006. Am J Ther. 2003. PMID: 12522516

4

Blood substitutes as pharmacotherapies in clinical practice.

Jahr JS, Walker V, Manoochehri K. Jahr JS, et al. Curr Opin Anaesthesiol. 2007 Aug;20(4):325-30. doi: 10.1097/ACO.0b013e328172225a. Curr Opin Anaesthesiol. 2007. PMID: 17620840 Review.

5

HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.

Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. Jahr JS, et al. J Trauma. 2008 Jun;64(6):1484-97. doi: 10.1097/TA.0b013e318173a93f. J Trauma. 2008. PMID: 18545113 Clinical Trial.

6

HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation).

Jahr JS, Moallempour M, Lim JC. Jahr JS, et al. Expert Opin Biol Ther. 2008 Sep;8(9):1425-33. doi: 10.1517/14712598.8.9.1425. Expert Opin Biol Ther. 2008. PMID: 18694360 Review.

7

Does HBOC-201 (Hemopure) affect platelet function in orthopedic surgery: a single-site analysis from a multicenter study.

Jahr JS, Liu H, Albert OK, Gull A, Moallempour M, Lim J, Gosselin R. Jahr JS, et al. Am J Ther. 2010 Mar-Apr;17(2):140-7. doi: 10.1097/MJT.0b013e3181a2b08d. Am J Ther. 2010. PMID: 19417588 Free article. Clinical Trial.

8

Are Hemoglobin-Based Oxygen Carriers Being Withheld Because of Regulatory Requirement for Equivalence to Packed Red Blood Cells?

Mackenzie CF, Pitman AN, Hodgson RE, Sussman MJ, Levien LJ, Jahr JS, Greenburg AG. Mackenzie CF, et al. Among authors: jahr js. Am J Ther. 2015 Jul-Aug;22(4):e115-21. doi: 10.1097/MJT.0000000000000009. Am J Ther. 2015. PMID: 25285795 No abstract available.

9

Blood Component Requirements and Erythrocyte Transfusion and Mortality Related to Hemoglobin Deficit in Phase III Trial of Hemoglobin-Based Oxygen Carrier: HBOC-201.

Jahr JS, Williams JP. Jahr JS, et al. Am J Ther. 2022 May-Jun 01;29(3):e279-e286. doi: 10.1097/MJT.0000000000001494. Epub 2022 Apr 14. Am J Ther. 2022. PMID: 35421008 Clinical Trial.

10

A novel approach to measuring circulating blood volume: the use of a hemoglobin-based oxygen carrier in a rabbit model.

Jahr JS, Lurie F, Xi S, Golkaryeh M, Kuznetsova O, Kullar R, Driessen B. Jahr JS, et al. Anesth Analg. 2001 Mar;92(3):609-14. doi: 10.1097/00000539-200103000-00010. Anesth Analg. 2001. PMID: 11226086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters